What type of study is this?

This is a Literature Review study.

Tranexamic Acid in Pediatric Cardiac Surgery: A Comprehensive Review of Efficacy, Safety, and Current Controversies

View Full Paper

Ask AI

Bookmark

TXA significantly reduces postoperative blood loss and the need for allogeneic transfusions, especially in high-risk pediatric patients.
Infants and cyanotic patients benefit most from TXA, yet dosing regimens vary widely across studies, complicating standardization.
Analysis highlights potential dose-dependent seizure risks associated with TXA use, warranting cautious application in pediatric cases.
The need for prospective trials is critical to establish consistent dosing strategies and evaluate long-term neurological outcomes.

No takes yet. Share an insight, caveat, or question.

Comprehensive review reveals tranexamic acid reduces bleeding in pediatric cardiac surgery, suggesting optimized dosing is necessary.

Bereza et al. (2025) studied this question.

View Full Paper

Ask AI

Bookmark